BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16476388)

  • 1. [Study on patient satisfaction with the treatment of mycosis on the extremities with terbinafine (SETTA)].
    Sánchez-Schmidt JM; Giménez-Jovani S; Peyrí-Rey J
    Actas Dermosifiliogr; 2005 Jun; 96(5):285-90. PubMed ID: 16476388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection.
    Bräutigam M; Nolting S; Schopf RE; Weidinger G
    Br J Dermatol; 1996 Jun; 134 Suppl 46():18-21: discussion 38. PubMed ID: 8763463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus.
    Tausch I; Decroix J; Gwiezdzinski Z; Urbanowski S; Baran E; Ziarkiewicz M; Levy G; Del Palacio A
    Int J Dermatol; 1998 Feb; 37(2):140-2. PubMed ID: 9542675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
    Tatsumi Y; Yokoo M; Senda H; Kakehi K
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itraconazole and terbinafine in perspective. From petri dish to patient.
    De Doncker P; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onychomycosis and terbinafine.
    Lancet; 1990 Mar; 335(8690):636. PubMed ID: 1969022
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis.
    Savin RC
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):807-9. PubMed ID: 2229529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
    Lebwohl M; Elewski B; Eisen D; Savin RC
    Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Terbinafine (Lamisil)].
    Breton MC
    Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
    [No Abstract]   [Full Text] [Related]  

  • 10. Results from a Phase 1/2 trial of BB2603, a terbinafine-based topical nano-formulation, in onychomycosis and tinea pedis.
    Fuhr R; Cook D; Ridden J; Nield K; Leigh E; Cook J; Davies-Strickleton H; Dobmeyer J
    Mycoses; 2022 Jun; 65(6):661-669. PubMed ID: 35466481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tinea pedis: clinical experience and efficacy of short treatment.
    Evans EG
    Dermatology; 1997; 194 Suppl 1():3-6. PubMed ID: 9154392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Itraconazole and terbinafine in perspective: from petri dish to patient.
    De Doncker P
    J Eur Acad Dermatol Venereol; 1999 Sep; 12 Suppl 1():S10-6; discussion S17. PubMed ID: 10509936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terbinafine: an oral and topical antifungal agent.
    Shear NH; Villars VV; Marsolais C
    Clin Dermatol; 1991; 9(4):487-95. PubMed ID: 1840406
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of treatment of severe tinea pedis with 1% terbinafine cream in members of the Japanese self-defense forces.
    Noguchi H; Hiruma M; Kawada A
    Mycoses; 1999; 42(7-8):479-84. PubMed ID: 10546490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: results of placebo-controlled multicenter trials.
    Savin R; Atton AV; Bergstresser PR; Elewski B; Jones HE; Levine N; Leyden J; Monroe A; Pandya A; Shupack J
    J Am Acad Dermatol; 1994 Apr; 30(4):663-7. PubMed ID: 8157801
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and tolerability of terbinafine 1% emulsion gel in patients with tinea pedis.
    Hollmen KA; Kinnunen T; Kiistala U; Väänänen A; Saarelainen IO; De CC; Decroix J; Broeckx W; Karvonen J
    J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):87-8. PubMed ID: 11952304
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-duration oral terbinafine for the treatment of tinea pedis in HIV-positive patients.
    Smith S; Houpt K; Rich P; LaMarca A; Weinberg JM; Alferez TS; Atillasoy E; Opper C
    Cutis; 2001 Jul; 68(1 Suppl):30-9. PubMed ID: 11499332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazole.
    Elewski B; Bergstresser PR; Hanifin J; Lesher J; Savin R; Shupack J; Stiller M; Tschen E; Zaias N; Birnbaum JE
    J Am Acad Dermatol; 1995 Feb; 32(2 Pt 1):290-2. PubMed ID: 7829722
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
    Korting HC; Kiencke P; Nelles S; Rychlik R
    Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trial.
    James IG; Loria-Kanza Y; Jones TC
    J Dermatolog Treat; 2007; 18(3):163-8. PubMed ID: 17538805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.